How Hims & Hers Built a Clinical-Scale Moat — 20VC (Andrew Dudum)

Hook: How a consumer healthcare brand turned digital scale into a real clinical moat and slashed drug prices. This original ~68-minute 20VC interview with Harry Stebbings is condensed to a 15-minute summary that gives you the strategic highlights fast. Learn how Andrew Dudum scaled Hims & Hers to a $4.3B market cap on $2.3B revenue by prioritizing talent, rigorous clinical protocols, and deliberate product launches across ED, hair, weight loss, peptides, and diagnostics. Hear why public markets sharpened the business, how AI is being deployed across marketing, design, and clinical decisioning, and why pharmacy fulfillment and clinician scale create an enduring competitive advantage. Andrew also breaks down the GLP-1 pricing disruption, the role of at-home diagnostics and prevention, mistakes he learned from, and his focus on retention over acquisition. Topics covered: AI, clinical operations, drug pricing, diagnostics, consumer healthcare, startups, and venture strategy. Listen now to get the key ideas in minutes.